{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:26:30Z","timestamp":1789748790895,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00520-023-07960-8","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T04:06:42Z","timestamp":1693282002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of chemotherapy and different chemotherapy regimens on bone health among Chinese breast cancer women in different menstrual status: a self-control study"],"prefix":"10.1007","volume":"31","author":[{"given":"Bai-qing","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-quan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-han","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-ling","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-quan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"issue":"3","key":"7960_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"7960_CR2","doi-asserted-by":"publisher","unstructured":"Ferlay J, Colombet M, Soerjomataram I et al (2021) Cancer statistics for the year 2020: an overview. Int J Cancer. https:\/\/doi.org\/10.1002\/ijc.33588","DOI":"10.1002\/ijc.33588"},{"issue":"1","key":"7960_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","volume":"50","author":"M Akram","year":"2017","unstructured":"Akram M, Iqbal M, Daniyal M et al (2017) Awareness and current knowledge of breast cancer. Biol Res 50(1):33. https:\/\/doi.org\/10.1186\/s40659-017-0140-9","journal-title":"Biol Res"},{"issue":"5","key":"7960_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11864-021-00835-2","volume":"22","author":"A Diana","year":"2021","unstructured":"Diana A, Carlino F, Giunta EF et al (2021) Cancer treatment-induced bone loss (CTIBL): state of the art and proper management in breast cancer patients on endocrine therapy. Curr Treat Options Oncol 22(5):45. https:\/\/doi.org\/10.1007\/s11864-021-00835-2","journal-title":"Curr Treat Options Oncol"},{"issue":"11","key":"7960_CR5","doi-asserted-by":"publisher","first-page":"6957","DOI":"10.1007\/s00520-021-06231-8","volume":"29","author":"Y Nisha","year":"2021","unstructured":"Nisha Y, Dubashi B, Bobby Z et al (2021) Effect of cytotoxic chemotherapy on bone health among breast cancer patients. Does it require intervention? Support Care Cancer 29(11):6957\u20136972. https:\/\/doi.org\/10.1007\/s00520-021-06231-8","journal-title":"Support Care Cancer"},{"issue":"4","key":"7960_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00198-008-0721-0","volume":"20","author":"Z Chen","year":"2009","unstructured":"Chen Z, Maricic M, Aragaki AK et al (2009) Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative. Osteoporos Int 20(4):527\u2013536. https:\/\/doi.org\/10.1007\/s00198-008-0721-0","journal-title":"Osteoporos Int"},{"issue":"1","key":"7960_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00520-013-1967-4","volume":"22","author":"LJ Peppone","year":"2014","unstructured":"Peppone LJ, Mustian KM, Rosier RN et al (2014) Bone health issues in breast cancer survivors: a Medicare Current Beneficiary Survey (MCBS) study. Support Care Cancer 22(1):245\u2013251. https:\/\/doi.org\/10.1007\/s00520-013-1967-4","journal-title":"Support Care Cancer"},{"issue":"12","key":"7960_CR8","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00198-020-05497-8","volume":"31","author":"S Rozenberg","year":"2020","unstructured":"Rozenberg S, Al-Daghri N, Aubertin-Leheudre M et al (2020) Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis? Osteoporos Int 31(12):2271\u20132286. https:\/\/doi.org\/10.1007\/s00198-020-05497-8","journal-title":"Osteoporos Int"},{"issue":"1","key":"7960_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bmb\/ldaa005","volume":"133","author":"MA Clynes","year":"2020","unstructured":"Clynes MA, Harvey NC, Curtis EM et al (2020) The epidemiology of osteoporosis. Br Med Bull 133(1):105\u2013117. https:\/\/doi.org\/10.1093\/bmb\/ldaa005","journal-title":"Br Med Bull"},{"key":"7960_CR10","doi-asserted-by":"publisher","unstructured":"Shapiro CL (2020) Osteoporosis: a long-term and late-effect of breast cancer treatments. Cancers 12(11). https:\/\/doi.org\/10.3390\/cancers12113094","DOI":"10.3390\/cancers12113094"},{"issue":"18","key":"7960_CR11","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.ejca.2009.09.026","volume":"45","author":"P Hadji","year":"2009","unstructured":"Hadji P, Ziller M, Maskow C et al (2009) The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer. Eur J Cancer 45(18):3205\u20133212. https:\/\/doi.org\/10.1016\/j.ejca.2009.09.026","journal-title":"Eur J Cancer"},{"issue":"3","key":"7960_CR12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10549-010-0899-7","volume":"123","author":"DA Cameron","year":"2010","unstructured":"Cameron DA, Douglas S, Brown JE et al (2010) Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency? Breast Cancer Res Treat 123(3):805\u2013814. https:\/\/doi.org\/10.1007\/s10549-010-0899-7","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"7960_CR13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1089\/jwh.1.1999.8.949","volume":"8","author":"EE Lower","year":"1999","unstructured":"Lower EE, Blau R, Gazder P et al (1999) The risk of premature menopause induced by chemotherapy for early breast cancer. J Womens Health Gend Based Med 8(7):949\u2013954. https:\/\/doi.org\/10.1089\/jwh.1.1999.8.949","journal-title":"J Womens Health Gend Based Med"},{"issue":"5","key":"7960_CR14","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","volume":"14","author":"J Bines","year":"1996","unstructured":"Bines J, Oleske DM, Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14(5):1718\u20131729. https:\/\/doi.org\/10.1200\/JCO.1996.14.5.1718","journal-title":"J Clin Oncol"},{"issue":"6","key":"7960_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1159\/000506465","volume":"15","author":"C Yip","year":"2020","unstructured":"Yip C, Liem GS, Mo F et al (2020) Bone health in premenopausal chinese patients after adjuvant chemotherapy for early breast cancer. Breast Care 15(6):655\u2013666. https:\/\/doi.org\/10.1159\/000506465","journal-title":"Breast Care"},{"key":"7960_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/164_2019_340","volume":"262","author":"P Vestergaard","year":"2020","unstructured":"Vestergaard P (2020) Drugs causing bone loss. Handb Exp Pharmacol 262:475\u2013497. https:\/\/doi.org\/10.1007\/164_2019_340","journal-title":"Handb Exp Pharmacol"},{"issue":"5893","key":"7960_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","volume":"4","author":"RB Payne","year":"1973","unstructured":"Payne RB, Little AJ, Williams RB et al (1973) Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 4(5893):643\u2013646. https:\/\/doi.org\/10.1136\/bmj.4.5893.643","journal-title":"Br Med J"},{"issue":"2C","key":"7960_CR18","first-page":"1271","volume":"24","author":"ME Kailaj\u00e4rvi","year":"2004","unstructured":"Kailaj\u00e4rvi ME, Salminen EK, Paija OM et al (2004) Serum bone markers in breast cancer patients during 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy. Anticancer Res 24(2C):1271\u20131274","journal-title":"Anticancer Res"},{"issue":"7","key":"7960_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1210\/js.2018-00052","volume":"2","author":"P Taxel","year":"2018","unstructured":"Taxel P, Faircloth E, Idrees S et al (2018) Cancer treatment-induced bone loss in women with breast cancer and men with prostate cancer. J Endocr Soc 2(7):574\u2013588. https:\/\/doi.org\/10.1210\/js.2018-00052","journal-title":"J Endocr Soc"},{"issue":"2","key":"7960_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.22088\/cjim.8.2.91","volume":"8","author":"R Safaei-Nodehi","year":"2017","unstructured":"Safaei-Nodehi R, Esmaili J, Sharifian R et al (2017) Does adjuvant chemotherapy change bone mineral density and related serum biomarkers in women with breast cancer? Caspian J Intern Med 8(2):91\u201398. https:\/\/doi.org\/10.22088\/cjim.8.2.91","journal-title":"Caspian J Intern Med"},{"issue":"6","key":"7960_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3892\/mco.2018.1615","volume":"8","author":"CT Axelsen","year":"2018","unstructured":"Axelsen CT, Jensen AB, Jakobsen EH et al (2018) Bone loss during neoadjuvant\/adjuvant chemotherapy for early stage breast cancer: a retrospective cohort study. Mol Clin Oncol 8(6):767\u2013772. https:\/\/doi.org\/10.3892\/mco.2018.1615","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"7960_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10549-020-05566-w","volume":"180","author":"M Kim","year":"2020","unstructured":"Kim M, Kim H, Ahn SH et al (2020) Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients. Breast Cancer Res Treat 180(3):657\u2013663. https:\/\/doi.org\/10.1007\/s10549-020-05566-w","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"7960_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s002230020039","volume":"70","author":"JH Davies","year":"2002","unstructured":"Davies JH, Evans BA, Jenney ME et al (2002) In vitro effects of chemotherapeutic agents on human osteoblast-like cells. Calcif Tissue Int 70(5):408\u2013415. https:\/\/doi.org\/10.1007\/s002230020039","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"7960_CR24","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1359\/jbmr.1997.12.11.1874","volume":"12","author":"DR Young","year":"1997","unstructured":"Young DR, Virolainen P, Inoue N et al (1997) The short-term effects of cisplatin chemotherapy on bone turnover. J Bone Miner Res 12(11):1874\u20131882. https:\/\/doi.org\/10.1359\/jbmr.1997.12.11.1874","journal-title":"J Bone Miner Res"},{"issue":"6","key":"7960_CR25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40265-020-01295-y","volume":"80","author":"C Kang","year":"2020","unstructured":"Kang C, Syed YY (2020) Atezolizumab (in combination with nab-paclitaxel): a review in advanced triple-negative breast cancer. Drugs 80(6):601\u2013607. https:\/\/doi.org\/10.1007\/s40265-020-01295-y","journal-title":"Drugs"},{"issue":"10","key":"7960_CR26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1634\/theoncologist.10-10-780","volume":"10","author":"S Gl\u00fcck","year":"2005","unstructured":"Gl\u00fcck S (2005) Adjuvant chemotherapy for early breast cancer: optimal use of epirubicin. Oncologist 10(10):780\u2013791. https:\/\/doi.org\/10.1634\/theoncologist.10-10-780","journal-title":"Oncologist"},{"issue":"7","key":"7960_CR27","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1002\/jcp.23034","volume":"227","author":"T Shandala","year":"2012","unstructured":"Shandala T, Shen NY, Hopwood B et al (2012) The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss. J Cell Physiol 227(7):2889\u20132897. https:\/\/doi.org\/10.1002\/jcp.23034","journal-title":"J Cell Physiol"},{"issue":"3","key":"7960_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00774-015-0679-x","volume":"34","author":"C Fan","year":"2016","unstructured":"Fan C, Georgiou KR, McKinnon RA et al (2016) Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats. J Bone Miner Metab 34(3):277\u2013290. https:\/\/doi.org\/10.1007\/s00774-015-0679-x","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"7960_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-017-4308-3","volume":"165","author":"C Fan","year":"2017","unstructured":"Fan C, Georgiou KR, Morris HA et al (2017) Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model. Breast Cancer Res Treat 165(1):41\u201351. https:\/\/doi.org\/10.1007\/s10549-017-4308-3","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7960_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00774-008-0013-y","volume":"27","author":"M Takahashi","year":"2009","unstructured":"Takahashi M, Mizoguchi T, Uehara S et al (2009) Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners. J Bone Miner Metab 27(1):24\u201335. https:\/\/doi.org\/10.1007\/s00774-008-0013-y","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"7960_CR31","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/jcb.23423","volume":"113","author":"ES Ang","year":"2012","unstructured":"Ang ES, Pavlos NJ, Chim SM et al (2012) Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-\u03baB and ERK. J Cell Biochem 113(3):946\u2013955. https:\/\/doi.org\/10.1002\/jcb.23423","journal-title":"J Cell Biochem"},{"issue":"4","key":"7960_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2106\/00004623-198466040-00016","volume":"66","author":"GE Friedlaender","year":"1984","unstructured":"Friedlaender GE, Tross RB, Doganis AC et al (1984) Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am 66(4):602\u2013607","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"7960_CR33","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/jcb.20889","volume":"99","author":"CJ Xian","year":"2006","unstructured":"Xian CJ, Cool JC, Pyragius T et al (2006) Damage and recovery of the bone growth mechanism in young rats following 5-fluorouracil acute chemotherapy. J Cell Biochem 99(6):1688\u20131704. https:\/\/doi.org\/10.1002\/jcb.20889","journal-title":"J Cell Biochem"},{"key":"7960_CR34","doi-asserted-by":"publisher","unstructured":"Peymanfar Y, Su YW, Xian CJ (2022) Notch2 blockade mitigates methotrexate chemotherapy-induced bone loss and marrow adiposity. Cells 11(9). https:\/\/doi.org\/10.3390\/cells11091521","DOI":"10.3390\/cells11091521"},{"issue":"3","key":"7960_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1043\/0003-3219(1994)064<0175:WLABSA>2.0.CO;2","volume":"64","author":"HM Frost","year":"1994","unstructured":"Frost HM (1994) Wolff's Law and bone's structural adaptations to mechanical usage: an overview for clinicians. Angle Orthod 64(3):175\u2013188. https:\/\/doi.org\/10.1002\/jcb.23423","journal-title":"Angle Orthod"},{"issue":"3","key":"7960_CR36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H et al (2008) A reference standard for the description of osteoporosis. Bone 42(3):467\u2013475. https:\/\/doi.org\/10.1016\/j.bone.2007.11.001","journal-title":"Bone"},{"issue":"3","key":"7960_CR37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s001980050281","volume":"11","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Gl\u00fcer CC (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 11(3):192\u2013202. https:\/\/doi.org\/10.1007\/s001980050281","journal-title":"Osteoporos Int"},{"issue":"4","key":"7960_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1359\/JBMR.041214","volume":"20","author":"PD Delmas","year":"2005","unstructured":"Delmas PD, van de Langerijt L, Watts NB et al (2005) Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res 20(4):557\u2013563. https:\/\/doi.org\/10.1359\/JBMR.041214","journal-title":"J Bone Miner Res"},{"issue":"3","key":"7960_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/jama.285.3.320","volume":"285","author":"R Lindsay","year":"2001","unstructured":"Lindsay R, Silverman SL, Cooper C et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320\u2013323. https:\/\/doi.org\/10.1001\/jama.285.3.320","journal-title":"JAMA"},{"issue":"10","key":"7960_CR40","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero P, Hausherr E, Chapuy MC et al (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 11(10):1531\u20131538. https:\/\/doi.org\/10.1002\/jbmr.5650111021","journal-title":"J Bone Miner Res"},{"issue":"4","key":"7960_CR41","doi-asserted-by":"publisher","first-page":"e126053","DOI":"10.1371\/journal.pone.0126053","volume":"10","author":"Y Chen","year":"2015","unstructured":"Chen Y, Xu G, Yang F (2015) Effect of neoadjuvant chemotherapy on the serum levels of bone turnover markers in women with early-stage breast cancer. PloS One 10(4):e126053. https:\/\/doi.org\/10.1371\/journal.pone.0126053","journal-title":"PloS One"},{"issue":"2","key":"7960_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10549-012-2084-7","volume":"134","author":"W Jacot","year":"2012","unstructured":"Jacot W, Pouderoux S, Thezenas S et al (2012) Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. Breast Cancer Res Treat 134(2):709\u2013717. https:\/\/doi.org\/10.1007\/s10549-012-2084-7","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"7960_CR43","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1007\/s00520-016-3250-y","volume":"24","author":"C\u00d8 Christensen","year":"2016","unstructured":"Christensen C\u00d8, Cronin-Fenton D, Fr\u00f8slev T et al (2016) Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer. Support Care Cancer 24(10):4229\u20134236. https:\/\/doi.org\/10.1007\/s00520-016-3250-y","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07960-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07960-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07960-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T05:12:36Z","timestamp":1694754756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07960-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["7960"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07960-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2552873\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"5 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University. All procedures performed involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments. Informed consent was not obtained as this was a retrospective study, meeting the requirements for the informed consent waiver.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consented for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"540"}}